Nu-Med Plus (NUMD) Share-based Compensation (QoQ) (2012 - 2021)
Nu-Med Plus (NUMD) Share-based Compensation (QoQ) (2012 - 2021) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 208.96% |
| Dec 31, 2020 | -859.75% |
| Sep 30, 2020 | -85.68% |
| Jun 30, 2020 | 1,122.30% |
| Mar 31, 2020 | 156.65% |
| Dec 31, 2019 | -61.04% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 116.18% |
| Dec 31, 2018 | -148.36% |
| Sep 30, 2018 | 1,178.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 300.41% |
| Dec 31, 2017 | -200.00% |
| Dec 31, 2016 | 200.00% |
| Sep 30, 2016 | -121.99% |
| Dec 31, 2015 | -200.00% |
| Mar 31, 2015 | -99.92% |
| Dec 31, 2014 | 146.18% |
| Sep 30, 2014 | -27.93% |